Inclusion body myositis: review of recent literature.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed.

1. Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken.Acta neuropathologica · 2015
   Review
2. Formation of gelsolin amyloid fibrils in the rough endoplasmic reticulum of skeletal muscle in the gelsolin mouse model of inclusion body myositis: comparative analysis to human sporadic inclusion body myositis.Ultrastructural pathology · 2013
   Article
3. A Caenorhabditis elegans model system for amylopathy study.Journal of visualized experiments : JoVE · 2013
   Article
4. From soluble aβ to progressive aβ aggregation: could prion-like templated misfolding play a role?Brain pathology (Zurich, Switzerland) · 2013
   Review
5. Inclusion body myositis: therapeutic approaches.Degenerative neurological and neuromuscular disease · 2012
   Review
6. Expression of human amyloid precursor protein in the skeletal muscles of Drosophila results in age- and activity-dependent muscle weakness.BMC physiology · 2011
   Article
7. Inflammatory myopathies.Current treatment options in neurology · 2011
   Article
8. Sporadic inclusion body myositis: possible pathogenesis inferred from biomarkers.Current opinion in neurology · 2010
   Review
9. Theories of the pathogenesis of inclusion body myositis.Current rheumatology reports · 2010
   Review
10. Clinical applications of intravenous immunoglobulins in neurology.Clinical and experimental immunology · 2009
    Review
11. Vacuolar myopathy in a dog resembling human sporadic inclusion body myositis.Acta neuropathologica · 2009
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

Abstract

Indexed as